Home

Strides Pharma Science Ltd Quarterly Result

Image

Strides Pharma Science Ltd

NSE: STAR

Net Profit - Last Quarter

₹ 90.04 Cr.

Last updated on: Apr 18, 2025

Strides Pharma Science Ltd Quarterly Results Key Highlights

  • The revenue of Strides Pharma Science Ltd for the Dec '24 is ₹ 1160 crore as compare to the Sep '24 revenue of ₹ 1195 crore.
  • This represent the decline of -2.94%a1# The ebitda of Strides Pharma Science Ltd for the Dec '24 is ₹ 214.45 crore as compare to the Sep '24 ebitda of ₹ 208.49 crore.
  • This represent the growth of 2.86%a1# The net profit of Strides Pharma Science Ltd for the Dec '24 is ₹ 90.04 crore as compare to the Sep '24 net profit of ₹ 72.27 crore.
  • This represent the growth of 24.59%a1#.

Strides Pharma Science Ltd Quarterly Results Analysis

Market Price of Strides Pharma Science Ltd

1M

1Y

3Y

5Y

Monitoring Strides Pharma Science Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 2025652.75
16 Apr 2025666.3
15 Apr 2025619.05
11 Apr 2025615.1
09 Apr 2025584.05
08 Apr 2025593.95
07 Apr 2025577.4
04 Apr 2025622.65
03 Apr 2025699.55
02 Apr 2025669.65

Historical Revenue of Strides Pharma Science Ltd

No data available

* All values are in crore

Historical EBITDA of Strides Pharma Science Ltd

No data available

* All values are in crore

Historical Net Profit of Strides Pharma Science Ltd

No data available

* All values are in crore

Strides Pharma Science Ltd News Hub

Strides Alathur successfully concludes USFDA inspection

Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab

Read more

19 Aug 24

Strides Pharma arm gets EIR from USFDA for Chennai facility

The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US

Read more

19 Aug 24

Strides Pharma hits 52-week high after dissolution of US unit

Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the

Read more

16 Aug 24

Strides Pharma Science to hold EGM

Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be

Read more

09 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Strides Pharma Science Ltd

What key financial metrics are included in Strides Pharma Science Ltd's quarterly results?

Key financial metrics in Strides Pharma Science Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Strides Pharma Science Ltd announce its quarterly results?

Strides Pharma Science Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Strides Pharma Science Ltd's quarterly performance impact its stock price?

Strides Pharma Science Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Strides Pharma Science Ltd's quarterly results on dividends?

The impact of Strides Pharma Science Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Strides Pharma Science Ltd's quarterly results?

Yes, Strides Pharma Science Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions